Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019
Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …

News

Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027

June 19, 2019
Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma

The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …

News
merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019
Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …

News
european_commission_web_5

EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms

June 19, 2019
Research and Development EU, counterfeit, generics, pharma, sales

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …

News
16792957331_d9572dbdf4_z

FDA expand Paragraph IV Patent Certifications List for generic drugmakers

June 19, 2019
Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …

News
lynparza

EU approval for MSD and AZ’s Lynparza in first-line BRCA-mutated advanced ovarian cancer

June 18, 2019
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …

News

Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours

June 18, 2019
Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma

Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

News
800px-paracetamol_acetaminophen_500_mg_pills

MHRA recall M&A Pharmachem’s paracetamol due to fungal contamination

June 18, 2019
Manufacturing and Production Contamination, MHRA, fungal, paracetamol, pharma

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachem’s 500mg paracetamol tablets. The …

News
novo_flag

FDA approves Novo Nordisk’s Victoza for children with type 2 diabetes

June 18, 2019
Manufacturing and Production GLP-1, Novo Nordisk, Victoza, diabetes, liraglutide

The FDA has approved Novo Nordisk’s Victoza (liraglutide) for paediatric patients aged 10 years and older with type 2 diabetes. …

News

Pfizer buy Array BioPharma for $11.4 billion

June 18, 2019
Manufacturing and Production

Pfizer has said it will acquire Colorado-based cancer specialist Array BioPharma for $11.4 billion. Pfizer has announced that it has …

News

Boehringer Ingelheim open new plant in Catalonia

June 17, 2019
Sales and Marketing Boehringer Ingelheim, Catalonia, Sant Cugat de Valles, barcelona, pharma

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona. The new …

News
facilities_lg06

Dr Reddy’s sells of two migraine treatments to Upsher-Smith Laboratories in deal worth $110 million

June 17, 2019
Sales and Marketing

Indian firm Dr Reddy’s has agreed to sell two migraine treatments to American firm Upsher-Smith Laboratories in a deal worth …

News
image_credit_united_states_mission_geneva

WHO decide not to declare global emergency

June 17, 2019
Sales and Marketing Ebola, UN, WHO, global emergency, health, pharma

The WHO has decided not to declare the Ebola crisis in the Congo a global emergency. While the WHO said …

News
29496564944_a9faceb1c2_z

Drugmakers sue Trump over prices in TV ads

June 17, 2019
Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …

News
16578744517_ed4293d3e7_z

Patient dies after receiving faecal transplant

June 17, 2019
Sales and Marketing Adverse Event, E.Coli. AMR, FDA, faecal transplant, pharma

A person has died after experiencing an adverse event related to a faecal transplant. The FDA has warned that two …

News
millerblockchainadj-1600x1200

The missing link: Blockchain in clinical data management

June 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, blockchain, data, data management, pharma, supply chain

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …

Feature
gilead_hq_at_stockley_park_london_2

Gilead inks deal with Canadian antibody discovery firm AbCellera

June 14, 2019
Medical Communications AbCellera, Gilead, monoclonal antibodies, pharma

Gilead has entered into an agreement with Canadian monoclonal antibody discovery firm AbCellera. The two firms will take part in …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma

Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …

News
merckincweb2

FDA ask MSD to join blockchain supply chain network

June 14, 2019
Medical Communications FDA, MSD, Merck, blockchain, supply chain

The FDA has asked MSD to join a shared permission blockchain network to help track and trace prescription medicines and …

News
teva_copy

Teva recall heart drug after carcinogen found in API

June 14, 2019
Medical Communications API, Contamination, NMDA, Teva, carcinogen, pharma, recall

Teva Pharmaceuticals has expanded its recall of losartan potassium tablets after detecting a possible carcinogen in an active pharmaceutical ingredient …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026